![Benjamin Looker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benjamin Looker
General Counsel bei
ESPERION THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Benjamin O.
Looker is Secretary & General Counsel at Esperion Therapeutics, Inc. since 2022.
Formerly, Mr. Looker was Associate General Counsel-Oncology at Merck KGaA, General Counsel at Trillium Therapeutics, Inc. in 2021, Associate at Goodwin Procter LLP, and VP, Head-US Legal & Global Business Operations at MorphoSys US, Inc. from 2019 to 2021.
Education includes undergraduate studies at Boston College and graduate studies at Boston College Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.06.2026 | 667.524 ( 0,26 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Benjamin Looker
| Unternehmen | Position | Beginn |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | General Counsel | 01.01.2022 |
Ehemalige bekannte Positionen von Benjamin Looker
| Unternehmen | Position | Ende |
|---|---|---|
| TRILLIUM THERAPEUTICS | General Counsel | 01.11.2021 |
MorphoSys US, Inc. | General Counsel | 01.04.2021 |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | - |
| MERCK KGAA | Corporate Officer/Principal | - |
Ausbildung von Benjamin Looker
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College Law School
 Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MorphoSys US, Inc. | Health Technology |
